Founded by Anmol Ajay Saxena, Ashva offers cutting-edge medical devices designed to assess and improve knee health with precision and ease
Ashva showcased its groundbreaking product Fitknees, an AI-powered wearable device that diagnoses knee health in just 10 minutes
With over 6 crore Indians diagnosed with osteoarthritis each year and 2.5 lakh undergoing knee replacement surgeries annually, knee health is a growing concern
Ashva’s flagship product, Fitknees, combines artificial intelligence with user-friendly technology to diagnose and track knee health
Fitknees is paired with another device, Fitmust, for more comprehensive analysis. Together, the two products cost ₹7.5 lakh
The company’s devices are already being used in 115+ orthopedic hospitals and physiotherapy centers, including Apollo, Manipal, and Aster Hospitals
Ashva’s sales: 2021–22: ₹5.5 lakh. 2022–23: ₹15.5 lakh in revenue. 2023–24: ₹50 lakh, loss of ₹77 lakh. 2024–25 (Till Sept): ₹45 lakh, with losses reduced to ₹8 lakh
Ashva achieved profitability in October–November 2024, generating ₹17.5 lakh in sales during this period
Asking for ₹50 lakh in exchange for 1.25% equity, she highlighted Ashva’s potential to transform knee health diagnostics
Vinita saw the potential in Anmol’s vision. She offered ₹50 lakh for 4% equity, a deal that Anmol accepted, valuing the mentorship and financial backing